Back to top

Zacks.com Most Recent Articles

Zacks Equity Research

Northern Trust Broadens UHNW Direct Indexing Access via Envestnet

Analyst Blog

NTRS expands its UHNW offering by integrating its tax-managed direct indexing solution with Envestnet's advisor platform.

BLKNegative Net Change STTNegative Net Change NTRSNegative Net Change

Sreeja Deb

SSRM Stock Soars 216% YTD: What's the Right Strategy for Investors?

Analyst Blog

SSR Mining stock soars 216% in a year, fueled by soaring gold and silver prices, a major U.S. mine acquisition, rising production and an attractive valuation.

HBMNegative Net Change SSRMNegative Net Change WPMNegative Net Change

Subhasish Mukherjee

IREN Stock Trading at a P/S of 24.12X: Should You Buy, Sell or Hold?

Analyst Blog

IREN Limited trades at a lofty 24.12X P/S as its AI Cloud pipeline, Microsoft contract and rising earnings keep the stock in hold territory.

APLDPositive Net Change CLSKNegative Net Change CIFRNegative Net Change IRENNegative Net Change

Arghyadeep Bose

Is OPFI's Underwriting Engine the Key Profitability Catalyst?

Analyst Blog

OppFi's Model 6 underwriting engine drives outsized profit gains as Q3 net income jump 136.9% y/y on 13.5% revenue growth and higher auto approvals.

FISNegative Net Change EVTCNegative Net Change OPFINegative Net Change

Zacks Equity Research

BFLY to Extend 3D Imaging Capabilities to Butterfly Garden Developers

Analyst Blog

Butterfly Network targets a 2026 Beam Steering API, opening core imaging to developers and enabling AI tools in Butterfly Garden.

VCYTPositive Net Change KRMDPositive Net Change SDGRPositive Net Change BFLYNegative Net Change

Zacks Equity Research

Franklin's December AUM Balance Rises Sequentially on Net Inflows

Analyst Blog

BEN's December AUM rose to $1.68T, fueled by $28B in net inflows, with gains across equity, fixed income, and alternative assets.

BENNo Net Change TROWNegative Net Change VCTRNegative Net Change

Rajani Lohia

Coca-Cola Trades Below 200-Day SMA: Opportunity or Warning Sign?

Analyst Blog

KO slips below its 200-day SMA as volumes weaken, raising questions about momentum, valuation and near-term upside.

KONegative Net Change COCOPositive Net Change PEPNegative Net Change MNSTPositive Net Change

Zacks Equity Research

Here's Why American Eagle Stock Looks Like a Buy Option Right Now

Analyst Blog

AEO delivered record Q3 revenue and upbeat profit guidance as comps turned positive, offsetting tariff pressure with demand and cost discipline.

AEONegative Net Change ULTANegative Net Change FIVENegative Net Change VSCONegative Net Change

Subhasish Mukherjee

Hut 8's Power Segment Under Pressure: Can New Contracts Offset Losses?

Analyst Blog

HUT's Power segment's revenues slide after a loss of the Ionic contract, but longer-term deals like American Bitcoin may restore stability, if monetized.

HIVEPositive Net Change HUTPositive Net Change BITFNegative Net Change

Tanuka De

Is Planet Labs Building Revenue Stability Through Government Deals?

Analyst Blog

PL leans into government contracts for revenue stability as its $734.5M backlog surges 216% year over year.

PLPositive Net Change RKLBNegative Net Change BKSYPositive Net Change

Nilanshi Mukherjee

ALAB Stock Rallies 20% in One Year: Should You Buy, Hold, or Sell?

Analyst Blog

Astera Labs is benefiting from rising AI connectivity demand and a broad product lineup, but competitive pressures and valuation concerns remain.

MRVLNegative Net Change AVGOPositive Net Change CRDOPositive Net Change ALABNegative Net Change

Ethan Feller

How to Trade the Magnificent 7 Stocks in 2026

Investment Ideas

Last year, shares of Amazon and Meta Platforms lagged, but this year could see a rebound. Meanwhile, Alphabet stock continues to rally

AMZNPositive Net Change AAPLNegative Net Change MSFTPositive Net Change NVDAPositive Net Change TSLAPositive Net Change GOOGLPositive Net Change METANegative Net Change

Zacks Equity Research

ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves

Analyst Blog

AngioDynamics reports flat Q2 earnings while revenue increase 8.8% and gross margin expands 170 bps on stronger Med Tech performance.

BSXPositive Net Change ANGONegative Net Change ISRGPositive Net Change MEDPNegative Net Change

Zacks Equity Research

MDU Resources Group Gains From Capital Investments, Spinoffs

Analyst Blog

MDU gains from heavy infrastructure investments and post-spinoff focus on energy delivery, with data center demand and capital plans driving long-term growth.

ATONegative Net Change MDUNegative Net Change SRNegative Net Change OGSPositive Net Change

Zacks Equity Research

Will Bunge Global (BG) Beat Estimates Again in Its Next Earnings Report?

Tale of the Tape

Bunge Global (BG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

BGNegative Net Change

Zacks Equity Research

Shell Secures Petrovietnam Gas' First Long-Term LNG Contract

Analyst Blog

SHEL wins Petrovietnam Gas' first long-term LNG contract, supplying 400,000 metric tons a year from 2027 and deepening its role in Vietnam's gas market.

FTIPositive Net Change CVENegative Net Change NGSNegative Net Change SHELNegative Net Change

Zacks Equity Research

Here's Why You Should Add PacBio Stock to Your Portfolio

Analyst Blog

PACB is gaining from product development and strong Q3 results, with Revio and Vega driving growth, though longer purchasing cycles remain a risk.

BSXPositive Net Change ISRGPositive Net Change PACBPositive Net Change MEDPNegative Net Change

Zacks Equity Research

Ross Stores' Q3 Comps Surge: Can Momentum Carry Into FY26?

Analyst Blog

ROST delivers a standout Q3 comp surge, strong revenue growth and an EPS beat, raising questions about whether momentum can extend into FY26.

AEONegative Net Change ROSTNegative Net Change BOOTNegative Net Change FIGSNegative Net Change

Zacks Equity Research

PSX Expands UK Footprint With Lindsey Refinery Asset Purchase

Analyst Blog

Phillips 66 agrees to buy the Lindsey Oil Refinery assets in the U.K., planning to integrate key infrastructure into its Humber operations to enhance the U.K.'s energy security.

VLOPositive Net Change PSXPositive Net Change PBFPositive Net Change PARRPositive Net Change

Zacks Equity Research

Can Innovation Revive Growth at Newell Despite Tariff Woes?

Analyst Blog

NWL is betting on consumer-led innovation to counter tariff pressure, lift core categories and rebuild growth despite a tough 2025 backdrop.

NWLPositive Net Change COCOPositive Net Change UNFINegative Net Change VFFNegative Net Change

Mrithunjoy Kaushik

Chipotle Scales Unit Growth: What's the Cannibalization Impact?

Analyst Blog

CMG highlights disciplined unit growth as new openings pressure comps modestly, while stable recovery timelines and strong early returns support expansion.

SBUXNegative Net Change CMGPositive Net Change SGPositive Net Change CAVAPositive Net Change

Zacks Equity Research

Reasons Why You Should Retain Paychex Stock in Your Portfolio

Analyst Blog

PAYX's growth is driven by rising SaaS adoption, the Paycor acquisition and AI launches, with FY26 revenues projected to rise 16.5% and earnings gains ahead.

PAYXPositive Net Change FRSHPositive Net Change FIVNNegative Net Change

Mrithunjoy Kaushik

Dutch Bros' New Shops Open Strong: Is Early Demand Scaling?

Analyst Blog

BROS sees strong early productivity from new shops, with record system-wide AUVs and rising demand supporting confidence in its expansion strategy.

SBUXNegative Net Change CMGPositive Net Change SGPositive Net Change BROSPositive Net Change

Zacks Equity Research

ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies

Analyst Blog

Alumis shares jump 95% after envudeucitinib meets all endpoints in two phase III plaque psoriasis studies, showing strong skin clearance.

AMGNPositive Net Change CRMDPositive Net Change EXASPositive Net Change ALMSPositive Net Change

Zacks Equity Research

JNJ's Nipocalimab Meets Goal in Phase II Study for Systemic Lupus

Analyst Blog

J&J's phase IIb JASMINE study on nipocalimab meets key endpoints in systemic lupus erythematosus, supporting plans to advance the drug into phase III.

JNJPositive Net Change CRMDPositive Net Change EXASPositive Net Change

Riya Anand

Should You Buy Goldman Stock as Macro Clarity Rekindles Dealmaking?

Analyst Blog

Can GS extend its run as dealmaking rebounds, restructuring sharpens focus, and capital returns stay strong into 2026? Let us find out.

GSNegative Net Change JPMNegative Net Change MSNegative Net Change

Zacks Equity Research

FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug

Analyst Blog

Alkermes wins FDA Breakthrough Therapy status for alixorexton in NT1 after Vibrance-1 data shows improvement in wakefulness.

ALKSPositive Net Change CRMDPositive Net Change IPSCPositive Net Change INDVPositive Net Change

Zacks Equity Research

4 Diversified Operations Stocks to Watch Despite Industry Headwinds

Industry Outlook

The prospects of the Zacks Diversified Operations industry are hindered by weaknesses in the manufacturing sector and ongoing supply chain challenges. HON, MMM, CIB and ITT are notable stocks in the industry.

HONNegative Net Change MMMNegative Net Change ITTNegative Net Change CIBPositive Net Change

Zacks Equity Research

Best Momentum Stocks to Buy for January 7th

Zacks #1 Rank Additions

LEU, ERO and ELA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 7th, 2026.

ERONegative Net Change LEUPositive Net Change ELAPositive Net Change

Zacks Equity Research

Company News for Jan 7, 2026

Corporate Summary

Companies in The News Are: XOM, AIG, STX, UNH

UNHNegative Net Change XOMNegative Net Change AIGNegative Net Change STXNegative Net Change